View : 133 Download: 47
Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: A 8-week prospective study
- Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: A 8-week prospective study
- Lee K.-S.; Han D.H.; Lee Y.-S.; Choo M.-S.; Yoo T.K.; Park H.J.; Yoon H.; Jeong H.; Lee S.J.; Kim H.; Park W.H.
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- Journal of Korean Medical Science
- Journal of Korean Medical Science vol. 25, no. 1, pp. 117 - 122
- SCIE; SCOPUS; KCI
- Document Type
- We evaluated the therapeutic effects of tamsulosin for women with non-neurogenic voiding dysfunction. Women who had voiding dysfunctions for at least 3 months were included. Inclusion criteria were age ≥18 yr, International Prostate Symptom Score (IPSS) of ≥15, and maximum flow rate (Qmax) of ≥12 mL/sec and/or postvoid residuals (PVR) of ≥150 mL. Patients with neurogenic voiding dysfunction or ana-tomical bladder outlet obstruction were excluded. All patients were classified accord-ing to the Blaivas-Groutz nomogram as having no or mild obstruction (group A) or moderate or severe obstruction (group B). After 8 weeks of treatment, treatment outcomes and adverse effects were evaluated. One hundred and six patients were evaluable (70 in group A, 36 in group B). After treatments, mean IPSS, bother scores, Qmax, PVR, diurnal and nocturnal micturition frequencies and scored form of the Bris-tol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS-SF) were changed significantly. Eighty-nine patients (84%) reported that the treatment was beneficial. The proportion of patients reported that their bladder symptoms caused "moderate to many severe problems" were significantly decreased. No significant difference were observed between the groups in terms of IPSS, bother score, Qmax, PVR, mic-turition frequency, and BFLUTS-SF changes. Adverse effects related to medication were dizziness (n=3), de novo stress urinary incontinence (SUI) (n=3), aggravation of underlying SUI (n=1), fatigue (n=1). Tamsulosin was found to be effective in female patients with voiding dysfunction regardless of obstruction grade. © 2010 The Korean Academy of Medical Sciences.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females.pdf(130.55 kB)
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.